Jefferson Health Plans EverWell (Health Partners Plans) · Zepbound and Wegovy coverage

Does Jefferson Health Plans EverWell (Health Partners Plans) cover Zepbound or Wegovy?

Last updated

GLP-1s for overweight or obesity alone are no longer covered since January 1, 2026.

If it is not covered: the lowest cash prices now

  • Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Without insurance: compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

GLP-1s for overweight or obesity alone are no longer covered since January 1, 2026. Only a new prior authorization showing a condition the drug is still covered for keeps it, and earlier approvals ended on December 31, 2025. In its words: "As of January 1, 2026, GLP-1 drugs for the treatment of overweight or obesity will no longer be covered unless your doctor submits a new prior authorization request. The new request must show that you have a condition for which a GLP-1 receptor remains a covered prescription drug benefit. Previously approved requests for GLP-1 drugs will end on December 31, 2025." (Jefferson Health Plans EverWell, GLP-1 Drug Coverage Changes, healthpartnersplans.com/medicaid/get-care/find-a-covered-drug/glp-1, Jan 1, 2026, read Nov 20, 2026). The change is Pennsylvania's and applies to every Pennsylvania Medicaid plan. In its words: "The Pennsylvania Department of Human Services is making this change which applies to all Pennsylvania Medicaid plans, including Jefferson Health Plans EverWell." (Jefferson Health Plans EverWell, GLP-1 Drug Coverage Changes, healthpartnersplans.com/medicaid/get-care/find-a-covered-drug/glp-1, Jan 1, 2026, read Nov 20, 2026). Members under 21 may still be covered for overweight or obesity alone. In its words: "Members under 21 years of age using a GLP-1 drug for overweight or obesity only may still be eligible for coverage." (Jefferson Health Plans EverWell, GLP-1 Drug Coverage Changes, healthpartnersplans.com/medicaid/get-care/find-a-covered-drug/glp-1, read Nov 20, 2026).

Questions

Jefferson Health Plans EverWell (Health Partners Plans), Zepbound and Wegovy: common questions

Does Jefferson Health Plans EverWell (Health Partners Plans) cover Zepbound for weight loss?

GLP-1s for overweight or obesity alone are no longer covered since January 1, 2026. Only a new prior authorization showing a condition the drug is still covered for keeps it, and earlier approvals ended on December 31, 2025. In its words: "As of January 1, 2026, GLP-1 drugs for the treatment of overweight or obesity will no longer be covered unless your doctor submits a new prior authorization request. The new request must show that you have a condition for which a GLP-1 receptor remains a covered prescription drug benefit. Previously approved requests for GLP-1 drugs will end on December 31, 2025." (Jefferson Health Plans EverWell, GLP-1 Drug Coverage Changes, healthpartnersplans.com/medicaid/get-care/find-a-covered-drug/glp-1, Jan 1, 2026, read Nov 20, 2026). The change is Pennsylvania's and applies to every Pennsylvania Medicaid plan. In its words: "The Pennsylvania Department of Human Services is making this change which applies to all Pennsylvania Medicaid plans, including Jefferson Health Plans EverWell." (Jefferson Health Plans EverWell, GLP-1 Drug Coverage Changes, healthpartnersplans.com/medicaid/get-care/find-a-covered-drug/glp-1, Jan 1, 2026, read Nov 20, 2026). Members under 21 may still be covered for overweight or obesity alone. In its words: "Members under 21 years of age using a GLP-1 drug for overweight or obesity only may still be eligible for coverage." (Jefferson Health Plans EverWell, GLP-1 Drug Coverage Changes, healthpartnersplans.com/medicaid/get-care/find-a-covered-drug/glp-1, read Nov 20, 2026). Zepbound not covered: the cash price at your dose

Does Jefferson Health Plans EverWell (Health Partners Plans) cover Wegovy for weight loss?

GLP-1s for overweight or obesity alone are no longer covered since January 1, 2026. Only a new prior authorization showing a condition the drug is still covered for keeps it, and earlier approvals ended on December 31, 2025. In its words: "As of January 1, 2026, GLP-1 drugs for the treatment of overweight or obesity will no longer be covered unless your doctor submits a new prior authorization request. The new request must show that you have a condition for which a GLP-1 receptor remains a covered prescription drug benefit. Previously approved requests for GLP-1 drugs will end on December 31, 2025." (Jefferson Health Plans EverWell, GLP-1 Drug Coverage Changes, healthpartnersplans.com/medicaid/get-care/find-a-covered-drug/glp-1, Jan 1, 2026, read Nov 20, 2026). The change is Pennsylvania's and applies to every Pennsylvania Medicaid plan. In its words: "The Pennsylvania Department of Human Services is making this change which applies to all Pennsylvania Medicaid plans, including Jefferson Health Plans EverWell." (Jefferson Health Plans EverWell, GLP-1 Drug Coverage Changes, healthpartnersplans.com/medicaid/get-care/find-a-covered-drug/glp-1, Jan 1, 2026, read Nov 20, 2026). Members under 21 may still be covered for overweight or obesity alone. In its words: "Members under 21 years of age using a GLP-1 drug for overweight or obesity only may still be eligible for coverage." (Jefferson Health Plans EverWell, GLP-1 Drug Coverage Changes, healthpartnersplans.com/medicaid/get-care/find-a-covered-drug/glp-1, read Nov 20, 2026). Wegovy not covered: the cash price at your dose

Does Pennsylvania Medicaid cover Wegovy or Zepbound for weight loss?

No. KFF found 16 programs covering GLP-1s for obesity treatment in October 2025, and Pennsylvania Medicaid is one of four that "have eliminated coverage of GLP-1s for obesity treatment" since (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026). KFF notes Pennsylvania covers one or more other weight-loss drugs, but no GLP-1. Every program must still cover some uses: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively". Pennsylvania Medicaid and GLP-1s: the state's words, and the cash price

Is Jefferson Health Plans EverWell (Health Partners Plans) dropping GLP-1 coverage for weight loss?

GLP-1s for overweight or obesity alone are no longer covered since January 1, 2026. Only a new prior authorization showing a condition the drug is still covered for keeps it, and earlier approvals ended on December 31, 2025. In its words: "As of January 1, 2026, GLP-1 drugs for the treatment of overweight or obesity will no longer be covered unless your doctor submits a new prior authorization request. The new request must show that you have a condition for which a GLP-1 receptor remains a covered prescription drug benefit. Previously approved requests for GLP-1 drugs will end on December 31, 2025." (Jefferson Health Plans EverWell, GLP-1 Drug Coverage Changes, healthpartnersplans.com/medicaid/get-care/find-a-covered-drug/glp-1, Jan 1, 2026, read Nov 20, 2026).

What do Zepbound and Wegovy cost if Jefferson Health Plans EverWell (Health Partners Plans) does not cover them?

Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 19, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked on pharmacy.amazon.com Nov 19, 2026 and on novocare.com Nov 11, 2026. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership) among sellers that serve Pennsylvania; compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership) among sellers that serve Pennsylvania. Every GLP-1's cash price without insurance

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a plan covers is decided by the plan and the employer or program behind it, and changes; check your own plan's drug list before you rely on this. This page reports the insurer's own published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.